Merck's (NYSE:MRK) Q4 CY2025 Sales Beat Estimates [Yahoo! Finance]
Merck & Company, Inc. (new) (MRK)
Last merck & company, inc. (new) earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.merck.com/home/default.aspx
Company Research
Source: Yahoo! Finance
On the other hand, the company's full-year revenue guidance of $66.25 billion at the midpoint came in 2% below analysts' estimates. Its non-GAAP profit of $2.04 per share was 1.5% above analysts' consensus estimates. Is now the time to buy Merck? Find out in our full research report Revenue: $16.4 billion vs analyst estimates of $16.12 billion (5% year-on-year growth, 1.8% beat) Adjusted EPS: $2.04 vs analyst estimates of $2.01 (1.5% beat) Adjusted EPS guidance for the upcoming financial year 2026 is $5.08 at the midpoint, missing analyst estimates by 9.8% Operating Margin: 20.9%, down from 27.5% in the same quarter last year Constant Currency Revenue rose 4% year on year (9% in the same quarter last year) Market Capitalization: $281.4 billion "In 2025, we continued to advance leading-edge science to deliver transformative medicines and vaccines that are improving health outcomes for patients around the world,” said Robert M. Davis, chairman and chief executive officer
Show less
Read more
Impact Snapshot
Event Time:
MRK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRK alerts
High impacting Merck & Company, Inc. (new) news events
Weekly update
A roundup of the hottest topics
MRK
News
- Merck and Pfizer decline vs the broader market as results released [Yahoo! Finance]Yahoo! Finance
- Merck tops quarterly estimates, posts modest 2026 guidance as generic competition looms [MSNBC.com]MSNBC.com
- China NMPA Approves Promega MSI Detection Kit as Companion Diagnostic for KEYTRUDA® [Yahoo! Finance]Yahoo! Finance
- Earnings Snapshot: Merck tops Q4, issues weaker-than-expected FY profit and sales outlook [Seeking Alpha]Seeking Alpha
- Merck in Charts: Q4 sees pharmaceutical sales up ~6% Y/Y, led by 7% rise in KEYTRUDA [Seeking Alpha]Seeking Alpha
MRK
Earnings
- 2/3/26 - Beat
MRK
Sec Filings
- 2/3/26 - Form 8-K
- 1/28/26 - Form 4
- 1/28/26 - Form 4
- MRK's page on the SEC website